Scholars Central

OtherPublished 22 Jul 2016

Certolizumab pegol for the treatment of rheumatoid arthritis

Authors: I Modesto, M Spinello, F Nicchi, M Cottone

Clinical Practice

Volume 8 · Issue 4 · Pages 391

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Rheumatoid arthritis (RA) is a chronic inflammatory disease that affects the joints. The cause of RA is unknown. TNF plays a pivotal role in the pathogenesis of RA. Since the late 1990s, the development of biologic agents that target TNF-a has revolutionized the approach to treating RA. Five inhibitors of TNF-a are currently available for clinical use. Certolizumab pegol is a novel TNF-a inhibitor, consisting of a humanized Fab fragment fused to a 40 KDa polyethylene glycol moiety. After a loading dose of 400 mg at weeks 0, 2 and 4, the drug is administered as maintenance therapy at 4-week intervals by subcutaneous injection. It is demonstrated that it improves the signs and symptoms of disease, quality of life and slows the progressive destruction of joints. Certolizumab pegol was generally well tolerated when used as a monotherapy or in combination with methotrexate, with most adverse events being of mild-to-moderate intensity, with a response rate similar to that of other biological therapy available for the treatment of RA. In conclusion, certolizumab pegol is an effective new option for the treatment of RA.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Practice.

All its articles

Article · 28 Mar 2025

Using

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Practice
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “I Modesto”
  • BylineArticles whose byline prints “M Spinello”
  • BylineArticles whose byline prints “F Nicchi”
  • BylineArticles whose byline prints “M Cottone”